journal article·2019-12-27

Synthesis of Au Nanoparticles in Natural Matrices by Liquid-Phase Plasma: Effects on Cytotoxic Activity against Normal and Cancer Cell Lines

Nidar Treesukkasem, Chayanaphat Chokradjaroen, Sewan Theeramunkong, Nagahiro Saito, Anyarat Watthanaphanit

ACS Applied Nano Materials· Volume 2· Issue 12
Publisher page

Abstract

Wrapping of gold nanoparticles (AuNPs) with a biocompatible matrix, to gain AuNP colloids, is a general strategy to synthesize the AuNPs for biomedical purposes. This work reports the synthesis of AuNP colloids in the aqueous solution of several natural matrices using a liquid-phase plasma process. Two classes of natural substances used are sugars (including: glucose, fructose, and sucrose) and biopolymers (including: carboxymethyl cellulose, sodium alginate, and gelatin). All are negatively charged water-soluble substances that are claimed to be sources of energy for cells to grow and have a high potential to be compatible with them. The study has emerged since one question arises: “Do these matrices also promote the growth of cancer cells?” The synthesis is performed by generating plasma across a pair of electrodes immersed in an aqueous solution of a natural matrix containing a gold precursor (HAuCl4·3H2O). Two concentrations of the matrices (0.5 and 1.0% w/v) are used, and the plasma treatment times are varied (0, 10, and 30 min). The effect of the type and concentration of natural matrices as well as the plasma treatment time on the formation of AuNPs, along with their physical and chemical properties, including morphology, size, hydrodynamic diameter (dh), colloidal stability, and charge on the AuNP surface, is evaluated. We find that the charge of the AuNP surfaces could be altered by the plasma treatment. Eventually, cytotoxicity test results against normal (MRC-5) and cancer (H460 and HeLa) cell lines could not only answer our opening question but also suggest a rather complex response. Our findings indicate the great potential of the obtained AuNP colloids as a part of cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Faculty of Science, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand

SIT Research Laboratories, Shibaura Institute of Technology, Tokyo 135-8548, Japan

Faculty of Pharmacy, Thammasat University, Pathumthani 12120, Thailand

Department of Chemical Systems Engineering, Graduate School of Engineering, Nagoya University, Chikusa-ku, Nagoya 464-8603, Japan

Funding

Mahidol University

References (60)

Show source-provided references
1. 10.1016/j.biomaterials.2016.06.01510.1016/j.biomaterials.2016.06.015 ↗
2. 10.1155/2016/549713610.1155/2016/5497136 ↗
3. 10.1021/la051371210.1021/la0513712 ↗
4. 10.3109/21691401.2014.95510710.3109/21691401.2014.955107 ↗
5. 10.1016/j.ejpb.2010.12.02910.1016/j.ejpb.2010.12.029 ↗
6. 10.1016/j.colsurfb.2010.07.01110.1016/j.colsurfb.2010.07.011 ↗
7. 10.1039/c2nr33776b10.1039/c2nr33776b ↗
8. 10.1016/j.colsurfb.2019.02.02510.1016/j.colsurfb.2019.02.025 ↗
9. 10.1016/j.colsurfa.2019.12369010.1016/j.colsurfa.2019.123690 ↗
10. 10.2147/IJN.S20322210.2147/IJN.S203222 ↗
11. 10.1016/j.jsps.2018.09.01110.1016/j.jsps.2018.09.011 ↗
12. 10.1002/bit.2251910.1002/bit.22519 ↗
13. 10.1021/nn205073n10.1021/nn205073n ↗
14. 10.3390/nano702003110.3390/nano7020031 ↗
15. 10.1016/j.cplett.2011.11.06510.1016/j.cplett.2011.11.065 ↗
16. 10.1088/0741-3335/54/12/12402710.1088/0741-3335/54/12/124027 ↗
17. 10.1007/s41614-017-0009-y10.1007/s41614-017-0009-y ↗
18. 10.1246/bcsj.2018028510.1246/bcsj.20180285 ↗
19. 10.1155/2015/12369610.1155/2015/123696 ↗
20. 10.7567/JJAP.57.0102A410.7567/JJAP.57.0102A4 ↗
21. 10.1351/pac20088009200310.1351/pac200880092003 ↗
22. 10.1039/C3RA45029E10.1039/C3RA45029E ↗
23. 10.1016/j.jtice.2014.09.00110.1016/j.jtice.2014.09.001 ↗
24. 10.1016/j.polymdegradstab.2013.01.01110.1016/j.polymdegradstab.2013.01.011 ↗
25. 10.2147/IJN.S3611110.2147/IJN.S36111 ↗
26. 10.3390/microarrays402013310.3390/microarrays4020133 ↗
27. 10.1136/bjo.2003.02757310.1136/bjo.2003.027573 ↗
28. 10.1186/s40824-015-0033-310.1186/s40824-015-0033-3 ↗
29. 10.1016/j.tsf.2009.07.15610.1016/j.tsf.2009.07.156 ↗
30. Pratt, C. W.; Cornely, K. Essential Biochemistry, 3rd ed. John Wiley & Sons: Hoboken, NJ, 2014; pp 290–303.
31. 10.1021/jp026920g10.1021/jp026920g ↗
32. 10.1021/jp201712a10.1021/jp201712a ↗
33. 10.1140/epjst/e2008-00462-010.1140/epjst/e2008-00462-0 ↗
34. 10.1088/1361-648X/aa60f310.1088/1361-648X/aa60f3 ↗
35. 10.4155/tde.12.2110.4155/tde.12.21 ↗
36. 10.1158/0008-5472.CAN-12-207110.1158/0008-5472.CAN-12-2071 ↗
37. 10.7567/JJAP.57.0102A310.7567/JJAP.57.0102A3 ↗
38. 10.1016/j.polymdegradstab.2013.07.00110.1016/j.polymdegradstab.2013.07.001 ↗
39. 10.1016/j.carbpol.2013.11.02510.1016/j.carbpol.2013.11.025 ↗
40. 10.1016/j.carbpol.2017.03.00610.1016/j.carbpol.2017.03.006 ↗
41. 10.1557/opl.2015.78710.1557/opl.2015.787 ↗
42. 10.1016/j.carbpol.2017.05.02510.1016/j.carbpol.2017.05.025 ↗
43. 10.1002/ppap.20120014810.1002/ppap.201200148 ↗
44. 10.1007/s11095-007-9257-910.1007/s11095-007-9257-9 ↗
45. 10.1016/j.jons.2017.06.00210.1016/j.jons.2017.06.002 ↗
46. 10.1002/aoc.288810.1002/aoc.2888 ↗
47. 10.1016/j.jinorgbio.2014.09.01310.1016/j.jinorgbio.2014.09.013 ↗
48. 10.1371/journal.pone.008104310.1371/journal.pone.0081043 ↗
49. 10.1002/smll.20070037810.1002/smll.200700378 ↗
50. 10.1002/adma.20080139310.1002/adma.200801393 ↗
51. 10.1021/la401556k10.1021/la401556k ↗
52. 10.1039/c0nr00478b10.1039/c0nr00478b ↗
53. 10.1021/nn501668a10.1021/nn501668a ↗
54. 10.1016/j.lfs.2005.09.03910.1016/j.lfs.2005.09.039 ↗
55. 10.1038/onc.2010.46610.1038/onc.2010.466 ↗
56. 10.2337/diabetes.52.11.279510.2337/diabetes.52.11.2795 ↗
57. 10.1016/S0140-6736(64)91328-510.1016/S0140-6736(64)91328-5 ↗
58. 10.1021/nn201624c10.1021/nn201624c ↗
59. 10.1038/cddis.2016.10510.1038/cddis.2016.105 ↗
60. 10.1016/j.biomaterials.2013.05.04310.1016/j.biomaterials.2013.05.043 ↗